These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12502446)

  • 1. [Clinical and histological features of fibrosing cholestatic hepatitis].
    Zhu Y; Luo K; Yu L
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):434-6. PubMed ID: 12502446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatal fibrosing cholestatic hepatitis following renal transplantation].
    Sprengers D; van Gelder T; Zondervan PE; Niesters HG; Janssen HL; de Man RA
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1380-4. PubMed ID: 12162178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis.
    Hung YB; Liang JT; Chu JS; Chen KM; Lee CS
    Hepatogastroenterology; 1995; 42(6):913-8. PubMed ID: 8847045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.
    Davies SE; Portmann BC; O'Grady JG; Aldis PM; Chaggar K; Alexander GJ; Williams R
    Hepatology; 1991 Jan; 13(1):150-7. PubMed ID: 1988336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
    Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.
    Al Faraidy K; Yoshida EM; Davis JE; Vartanian RK; Anderson FH; Steinbrecher UP
    Transplantation; 1997 Sep; 64(6):926-8. PubMed ID: 9326423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
    Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of fibrosing cholestatic hepatitis with lamivudine.
    Chan TM; Wu PC; Li FK; Lai CL; Cheng IK; Lai KN
    Gastroenterology; 1998 Jul; 115(1):177-81. PubMed ID: 9649474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrosing cholestatic hepatitis by B virus reactivation in AIDS].
    Poulet B; Chapel F; Dény P; Schneider MC; Jeantils V; Beaugrand M; Guettier C
    Ann Pathol; 1996; 16(3):188-91. PubMed ID: 8766176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients.
    Cotler SJ; Taylor SL; Gretch DR; Bronner MP; Rizk R; Perkins JD; Carithers RL
    Am J Gastroenterol; 2000 Mar; 95(3):753-9. PubMed ID: 10710070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
    Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
    Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
    Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.
    Jung S; Lee HC; Han JM; Lee YJ; Chung YH; Lee YS; Kwon Y; Yu E; Suh DJ
    J Gastroenterol Hepatol; 2002 Mar; 17(3):345-50. PubMed ID: 11982709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of CD4+CD25+ regulatory T cells in liver tissues of fibrosing cholestatic hepatitis after liver and kidney transplantation].
    Lang ZW; Shen B; Zhang L; Shi XH; Ma PQ; Lan MD; Ma ZC; Jin SH
    Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):667-71. PubMed ID: 17903368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
    Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.
    Rosenberg PM; Farrell JJ; Abraczinskas DR; Graeme-Cook FM; Dienstag JL; Chung RT
    Am J Gastroenterol; 2002 Feb; 97(2):478-83. PubMed ID: 11866292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.